申请人:SUNOVION PHARMACEUTICALS INC.
公开号:US20150126511A1
公开(公告)日:2015-05-07
The invention relates to novel cyclohexylamine derivatives and their use in the treatment and/or prevention of central nervous system (CNS) disorders, such as depression, anxiety, schizophrenia and sleep disorder as well as methods for their synthesis. The invention also relates to pharmaceutical compositions containing the compounds of the invention, as well as methods of inhibiting reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine from the synaptic cleft and methods of modulating one or more monoamine transporter.
本发明涉及新的环己胺衍生物及其在治疗和/或预防中枢神经系统(CNS)疾病,如抑郁症、焦虑症、精神分裂症和睡眠障碍方面的应用,以及它们的合成方法。本发明还涉及含有本发明化合物的制药组合物,以及抑制内源性单胺,如多巴胺、5-羟色胺和去甲肾上腺素从突触裂隙中再摄取的方法和调节一个或多个单胺转运体的方法。